Takumi Asada

Title: Takumi Asada: Innovator in Modified Release Formulations

Introduction

Takumi Asada is a notable inventor based in Hyogo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of modified release formulations. With a total of three patents to his name, Asada's work focuses on improving medication delivery and efficacy.

Latest Patents

Asada's latest patents include innovative modified release compositions in solid oral dosage forms. These formulations comprise amisulpride, presented as an unequal mixture of (R)-amisulpride and (S)-amisulpride, or their pharmaceutically acceptable salts. The key feature of these compositions is that the amount of (R)-amisulpride exceeds that of (S)-amisulpride. These medicaments are designed for the treatment of various diseases and disorders, with detailed methods of use, including specific dosage regimens. Additionally, Asada's patents explore formulations that utilize polymorphs of enantiomeric amisulpride, further enhancing the therapeutic potential of these medications.

Career Highlights

Takumi Asada is currently associated with Sunovion Pharmaceuticals Inc., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing the understanding and application of modified release technologies, which are crucial for improving patient outcomes.

Collaborations

Asada has collaborated with notable colleagues, including Gerald R Galluppi and Seth C Hopkins. These partnerships have contributed to the successful development and patenting of his innovative formulations.

Conclusion

Takumi Asada's contributions to the field of pharmaceuticals, particularly through his patents on modified release formulations, highlight his role as a key innovator. His work not only advances medication delivery systems but also enhances the treatment options available for various diseases and disorders.